Company intelligence / Profile preview

Microchips Biotech

Lexington, Massachusetts, United Statesmicrochipsltd.com ↗

Ownership: Private
Employees: ~15
Development stage: Other

Overview

Microchips Biotech developed a proprietary microchip-based implant capable of storing and wirelessly releasing precise doses of drugs over months or years. The technology was validated in a first-in-human clinical study delivering parathyroid hormone for osteoporosis and is being developed for long-term contraception with levonorgestrel. The company was acquired by Daré Bioscience in November 2019.

Therapeutic areas: EndocrinologyWomen's Health
Modalities: DeviceImplantable drug delivery device
Industry: Implantable Medical Devices

Partnerships

Teva Pharmaceutical Industries Ltd.Bill & Melinda Gates Foundation

Beyond the preview

Go deeper on Microchips Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microchips Biotech.